The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.
Daisuke Takahari
No relevant relationships to disclose
Tetsuya Hamaguchi
No relevant relationships to disclose
Kenichi Yoshimura
No relevant relationships to disclose
Hitoshi Katai
No relevant relationships to disclose
Seiji Ito
No relevant relationships to disclose
Nozomu Fuse
No relevant relationships to disclose
Taira Kinoshita
No relevant relationships to disclose
Hirofumi Yasui
No relevant relationships to disclose
Masanori Terashima
No relevant relationships to disclose
Masahiro Gotoh
No relevant relationships to disclose